The US has announced its plan to allocate 55 million doses of COVID-19 vaccines to the rest of the world as a second tranche, including 1.6 core jabs to 18 Asian countries such as India, Pakistan and Nepal as part of the Biden administration. Bid to end the pandemic globally.
Earlier this month, the Biden administration announced plans for the first 25 million vaccine doses, which the US has already begun shipping. Of the 55 million (5.50 crore) vaccine doses announced on Monday as the second tranche, 16 million (1.60 crore) have been allocated to 18 Asian countries such as India, Nepal, Bangladesh, Pakistan, Sri Lanka, Afghanistan, Maldives and Bhutan.
A White House fact sheet on Monday did not give exact figures on how many doses would be sent to each country. It only gave estimates for general areas. The Biden-Harris administration has so far allocated 80 million doses of its vaccine supply to the US, which President Joe Biden promised by the end of June as part of his efforts to end the pandemic globally.
“As we continue to fight the COVID-19 pandemic at home and work to end the pandemic around the world, President Biden has promised that the United States will have an arsenal of vaccines for the world. That plan Part of it is donating vaccines from our domestic supplies, and the president has promised to allocate 8 crore (8 crore) doses by the end of June,” the White House said.
For these 80 million doses, the US will share 75 percent through COVAX and 25 percent will be targeted to help combat the worldwide boom. The White House said, “Our goal is to increase global COVID-19 vaccination coverage, prepare for growth and prioritize healthcare workers and other vulnerable populations based on public health data and accept best practice and support our neighbors and other countries.” is to help.”
The Biden-Harris administration will not use its vaccines to secure favor in other countries, it stressed. Of the 41 million to be shared through COVAX, 14 million will be given to Latin America and the Caribbean countries and 16 million to Asia.
The doses will include Moderna, Pfizer and Johnson & Johnson COVID-19 vaccines. CNN reports that AstraZeneca’s vaccine has not been approved by federal regulators. Asian countries include India, Nepal, Bangladesh, Pakistan, Sri Lanka, Afghanistan, Maldives, Bhutan, Philippines, Vietnam, Indonesia, Thailand, Malaysia, Laos, Papua New Guinea, Taiwan, Cambodia and the Pacific Islands.
Another 100,000 crore jobs will be shared with African countries. The White House said that approximately 14 million (14 million) or 25 percent of these 55 million (55 million) vaccines would be shared with regional priorities and other recipients such as Colombia, Argentina, Haiti, other CARICOM countries, the Dominican Republic, Costa . Rica, Panama, Afghanistan, Bangladesh, Pakistan, Philippines, Vietnam, Indonesia, South Africa, Nigeria, Kenya, Ghana, Cabo Verde, Egypt, Jordan, Iraq, Yemen, Tunisia, Oman, West Bank and Gaza, Ukraine, Kosovo, Georgia , Moldova and Bosnia.
The Caribbean Community (CARICOM) is a regional grouping of Caribbean countries that includes Antigua and Barbuda, the Bahamas, Barbados, Belize, Commonwealth of Dominica, Grenada, Guyana, Jamaica, Haiti, Montserrat, St. Kitts and Nevis, St. Lucia, St. Vincent and the Grenadines, Suriname, and Trinidad and Tobago.
In addition to sharing doses from its own vaccine supplies, the White House said, the government is also committed to working with US manufacturers to produce more vaccines to share with the world. To that end, before the G7, Biden announced that the US would buy half a billion Pfizer doses and donate them to 92 low- and lower-middle-income countries and members of the African Union. Overall, the G7+ agreed to provide more than 100 million additional doses by the summer of 2021, the White House said.
“In addition, the US is committed to expanding local production of vaccines, and through our Quad partnership and the International Development Finance Corporation’s support for vaccine manufacturing, to over $1 billion (100 crore) in Africa and India in 2021.” The dosage will be produced by 2022,” it said.
“This vaccine strategy is an important component of our overall global effort to lead the world in the fight to defeat COVID-19 and achieve global health security,” the White House said.
(Except for the title, this story has not been edited by NDTV staff and is published from a syndicated feed.)